BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update

FDA Fast Track Designation for Plinabulin plus docetaxel marks key regulatory milestone in DUBLIN-4 study population of Post-ICI Non-Squamous NSCLC with no actionable genomic alteration (AGA)Strategic transaction with Biolin provides data from approximately half of DUBLIN-4’s 442 patients and suppo…